Association of parity with risk of type 2 diabetes and related metabolic disorders

Diabetes Care

Volumn 25, Issue 4, 2002, Pages 690-695

  Hanley, Anthony J G ^a,b   McKeown Eyssen, Gail ^a   Harris, Stewart B ^c   Hegele, Robert A ^d   Wolever, Thomas M S ^a   Kwan, Jeremy ^a   Zinman, Bernard ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; PROINSULIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY FAT; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; DIET RESTRICTION; FEMALE; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NULLIPARA; ORAL GLUCOSE TOLERANCE TEST; QUESTIONNAIRE; RISK FACTOR; SCHOOL CHILD; WAIST CIRCUMFERENCE; WORLD HEALTH ORGANIZATION; ADIPOSE TISSUE; ADOLESCENT; BLOOD; CHILD; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HISTOLOGY; HOMEOSTASIS; METABOLISM; MIDDLE AGED; PARITY; PHYSIOLOGY; PREVALENCE;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; C-PEPTIDE; CHILD; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; METABOLIC DISEASES; MIDDLE AGED; PARITY; PREVALENCE; PROINSULIN; RISK FACTORS;

EID: 0036549432     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.4.690     Document Type: Article

References (39)

1. Boyko EJ, Alderman BW, Keane EM, Baron AE: Effects of childbearing on glucose tolerance and NIDDM prevalence. Diabetes Care 13:848-854, 1990
2. Manson JE, Rimm EB, Colditz GA, Stampfer MJ, Willett WC, Arky RA, Rosner B, Hennekens CH, Speizer FE: Parity and incidence of non-insulin dependent diabetes mellitus. Am J Med 93:13-18 1992
3. O'Sullivan JB, Gordon T: Childbearing and Diabetes Mellitus. Washington, DC, National Center for Health Statistics, Vital and Health Statistics, 1966 (publ. no. 1000, ser. 11, no. 21)
4. Martin FIR, Hopper JL, Dean B, Campbell DG, Hammond P: Glucose tolerance and mortality in diabetes mellitus in Malteseborn residents of Victoria. Med J Aust 141: 93-97, 1984
5. Kritz-Silverstein D, Barrett-Connor E, Wingard DL: The effect of parity on the later development of non-insulin dependent diabetes mellitus or impaired glucose tolerance. N Engl J Med 321:1214-1219, 1989
6. Collins VR, Dowse GK, Zimmet PZ: Evidence against association between parity and NIDDM from five population groups. Diabetes Care 14:975-981, 1991
7. Alderman BW, Marshall JA, Boyko EJ, Markham KA, Baxter J, Hamman RF: Reproductive history, glucose tolerance, and NIDDM in Hispanic and non-Hispanic White women: the San Luis Valley Diabetes Study. Diabetes Care 16:1557-1563, 1993
8. Charles MA, Pettitt DJ, McCance DR, Hanson RL, Bennett PH, Knowler WC: Gravidity, obesity, and non-insulin dependent diabetes among Pima Indian women. Am J Med 97:250-255, 1994
9. Cowan LD, Go OT, Howard BV, Devereux RB, Pettitt DJ, Fabsitz RR, Lee ET, Welty TK: Parity, postmenaupausal estrogen use, and cardiovascular disease risk factors among American Indian women: the Strong Heart Study. J Women's Health 4:441-449, 1997
10. Kritz-Silverstein D, Barrett-Connor E, Wingard DL, Friedlander NJ: Relation of pregnancy history to insulin levels in older, nondiabetic women. Am J Epidemiol 140:375-382, 1994
11. Laakso M: How good a marker is insulin level for insulin resistance. Am J Epidemiol 137:959-956, 1993
12. Kahn SE, Halban PA: Release of incompletely processed proinsulin is the cause of disproportionate proinsulinaemia of NIDDM. Diabetes 46:1725-1732, 1997
13. Hanley AJG, Harris SB, Barnie A, Gittelsohn J, Wolever TMS, Logan A, Zinman B: The Sandy Lake Health and Diabetes Project: design, methods, and lessons learned. Chron Dis Canada 16:149-156, 1995
14. Harris SB, Gittelsohn J, Hanley AJG, Barnie A, Wolever TMS, Gao J, Logan A, Zinman B: The prevalence of NIDDM and associated risk factors in Native Canadians. Diabetes Care 20:185-187, 1997
15. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
16. Morgan CR, Lazarow A: Immunoassay of insulin: two antibody system: plasma insulin levels of normal subdiabetic and diabetic rats. Diabetes 12:115-126, 1963
17. Bowsher RR, Wolny JD, Frank BH: A rapid and sensitive radioimmunoassay for the measurement of proinsulin in human serum. Diabetes 41:1084-1090, 1992
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
19. SAS/STAT User's Guide: Version 6, 4th Edition. Cary, NC, SAS Inst., 1990
20. Simmons D, Williams R: Parity, ethnic group and the prevalence of non-insulin-dependent diabetes: the Coventry Diabetes Study (Abstract). Diabetes 40 (Suppl. 1):497A, 1991
21. Hanley AJ, McKeown-Eyssen G, Harris SB, Regele RA, Wolever TM, Kwan J, Connelly PW, Zinman B: Cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors in a population experiencing rapid cultural transition. Diabetes Care 24:1240-1247, 2001
22. Porte D Jr, Kahn SE: Hyperproinsulinaemia and amyloid in NIDDM. Clues to the etiology of islet beta cell function? Diabetes 38:1333-1336, 1989
23. Nagi DK, Knowler WC, Mohamed-Ali V, Bennett PH, Yudkin JS: Intact proinsulin, des 31,32 proinsulin and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes. Diabetes Care 21: 127-133, 1998
24. Haffner SM, Bowsher RR, Mykkanen L, Hazuda HP, Mitchell BD, Valdez RA, Gingerich R, Monterossa A, Stern MP: Proinsulin and specific insulin concentrations in high- and low-risk populations for NIDDM. Diabetes 43:1490-1493, 1994
25. Williams DRR, Byrne C, Clark PMS, Cox L, Day NE, Rayman G, Wang T, Hales CN: Raised proinsulin concentration as early indicator of beta-cell dysfunction. BMJ 303:95-96, 1991
26. Swinn RA, Wareham NJ, Gregory R, Curling V, Clark PM, Dalton KJ, Edwards OM, O'Rahilly S: Excessive secretion of insulin precursors characterizes and predicts gestational diabetes. Diabetes 44:911-915, 1995
27. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstom RW, Fujimoto WY: Proinsulin levels predict the development of non-insulin dependent diabetes mellitus (NIDDM) in Japanese-American men. Diabet Med 13: S63-S66, 1996
28. Inoue I, Takahashi K, Katayama S, Harada Y, Negishi K, Ishii J, Shibazaki S, Nagai M, Kawazu S: A higher proinsulin response to glucose loading predicts deteriorating fasting plasma glucose and worsening to diabetes in subjects with impaired glucose tolerance. Diabet Med 13:330-336, 1996
29. Nijpels G, Popp-Snijders CP, Kostense PJ, Bouter LM, Heine RJ: Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study. Diabetologia 39:113-118, 1996
30. Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Hales CN, Laakso M: Serum proinsulin levels are disproportionately in early prediabetic subjects. Diabetologia 35:1176-1182, 1995
31. Mykkanen L, Haffner SM, Hales CN, Ronnemaa T, Laakso M: The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects. Diabetes 46:1990-1995, 1997
32. Roder ME, Porte DJr., Schwartz RS, Kahn SE: Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:604-608, 1998
33. Mykkanen L, Zaccaro DJ, Hales CN, Festa A, Haffner SM: The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study. Diabetologia 42:1060-1066, 1999
34. Dunaif A, Segal KR, Futterweit W, Dobrjansky A: Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38: 1165-1174, 1989
35. Solomon CG: The epidemiology of polycystic ovary syndrome: prevalence and associated disease risk. Endocrinol Metab Clin North Am 28:247-264, 1999
36. O'Meara NM, Blackman JD, Ehrmann DA, Barnes RB, Jaspan JB, Rosenfield RL, Polonsky KS: Defects in β-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metdb 76:1241-1247, 1993
37. Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL, Polonsky KS: Insulin secretory defects in polycystic ovary syndrome: relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest 96:520-527, 1995
38. Dunaif A, Finegood DT: β-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:942-947, 1996
39. Harris SB, Caulfield LE, Sugamori ME, Whalen EA, Henning B: The epidemiology of diabetes in pregnant Native Canadians. Diabetes Care 20:1422-1425, 1997